Skip to content
10-K

Annual Report

Structure Therapeutics Inc. GPCR

0001104659-26-020562

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 15, 2026 212.53M sh
Shares Diluted FY 2025 · Dec 31, 2025 177.6M sh
Shares Diluted FY 2025 · Dec 31, 2024 157.92M sh
Shares Diluted FY 2025 · Dec 31, 2023 110.2M sh
Capex FY 2025 · Dec 31, 2025 $3.61M
Capex FY 2025 · Dec 31, 2024 $1.29M
Capex FY 2025 · Dec 31, 2023 $2.17M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$222.2M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$116.64M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$79.49M
Short Term Investments FY 2025 · Dec 31, 2025 $646.57M
Short Term Investments FY 2025 · Dec 31, 2024 $714.01M
Cash And Equivalents FY 2025 · Dec 31, 2025 $799.62M
Cash And Equivalents FY 2025 · Dec 31, 2024 $169.51M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.52B
Stockholders Equity FY 2025 · Dec 31, 2024 $864.84M
Stockholders Equity FY 2025 · Dec 31, 2023 $452.97M
Stockholders Equity FY 2025 · Dec 31, 2022 −$115.14M
Current Liabilities FY 2025 · Dec 31, 2025 $63.29M
Current Liabilities FY 2025 · Dec 31, 2024 $36.02M
Total Liabilities FY 2025 · Dec 31, 2025 $67.54M
Total Liabilities FY 2025 · Dec 31, 2024 $38.49M
Current Assets FY 2025 · Dec 31, 2025 $1.57B
Current Assets FY 2025 · Dec 31, 2024 $891.21M
Total Assets FY 2025 · Dec 31, 2025 $1.58B
Total Assets FY 2025 · Dec 31, 2024 $903.33M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.80
Eps Diluted FY 2025 · Dec 31, 2024 −$0.78
Eps Diluted FY 2025 · Dec 31, 2023 −$0.81
Eps Basic FY 2025 · Dec 31, 2025 −$0.80
Eps Basic FY 2025 · Dec 31, 2024 −$0.78
Eps Basic FY 2025 · Dec 31, 2023 −$0.81
Sga Expense FY 2025 · Dec 31, 2025 $61.55M
Sga Expense FY 2025 · Dec 31, 2024 $49.41M
Sga Expense FY 2025 · Dec 31, 2023 $32.67M
Rd Expense FY 2025 · Dec 31, 2025 $225.26M
Rd Expense FY 2025 · Dec 31, 2024 $108.81M
Rd Expense FY 2025 · Dec 31, 2023 $70.1M
Net Income FY 2025 · Dec 31, 2025 −$141.2M
Net Income FY 2025 · Dec 31, 2024 −$122.53M
Net Income FY 2025 · Dec 31, 2023 −$89.62M
Operating Income FY 2025 · Dec 31, 2025 −$176.56M
Operating Income FY 2025 · Dec 31, 2024 −$158.23M
Operating Income FY 2025 · Dec 31, 2023 −$102.78M